Increased plasma level of platelet-activating factor (PAF) and decreased serum PAF acetylhydrolase (PAFAH) activity in adults with bronchial asthma

Journal of Investigational Allergology and Clinical Immunology

Volumn 6, Issue 1, 1996, Pages 22-29

  Tsukioka, Kazuharu ^a   Matsuzaki, Masaharu ^b,c   Nakamata, Masami ^d   Kayahara, Hiroshi ^c   Nakagawa, Takemasa ^e  

^a NISHI NIIGATA CHUO NATIONAL HOSPITAL   (Japan)

^b SRL INC   (Japan)

^c SHINSHU UNIVERSITY   (Japan)

^d National Takada Hospital   (Japan)

^e ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bronchial asthma; Plasma PAF level; Pulmonary tuberculosis; Serum PAFAH activity

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; THROMBOCYTE ACTIVATING FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; RADIOIMMUNOASSAY;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADMINISTRATION, INHALATION; ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; AGE FACTORS; AGED; ALBUTEROL; AMINOPHYLLINE; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BECLOMETHASONE; BRONCHODILATOR AGENTS; FEMALE; HUMANS; HYDROCORTISONE; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; PHOSPHOLIPASES A; PLATELET ACTIVATING FACTOR; PROCATEROL; RADIOIMMUNOASSAY; RESPIRATORY FUNCTION TESTS; THEOPHYLLINE; TUBERCULOSIS;

EID: 0029913376     PISSN: 10189068     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Benveniste, J., Henson, P.M., Cochrane, C. Leukocyte-dependent histamine release from rabbit platelet. J Exp Med 1972, 136: 1356-77.
2. Demopoulos, C.A., Pinckard, R.N., Hanahan, D.J. Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Biol Chem 1979, 254: 9355-8.
3. Braquet, P., Touqui, L, Shen, T Y., Vargaftig, B B Perspectives in platelet-activating factor research. Pharmacol Rev 1987, 39: 97-145.
4. Blank, M.L, Lee, T-C, Fitzgerald, V., Snyder, F. A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid). J Biol Chem 1981, 256: 175-8.
5. International Consensus Report on the Diagnosis and Management of Asthma. Clin Exp Allergy 1992, 22 (Suppl.): 1-72.
6. Arerugli Shikkan Chiryo Gaidolain (in Japanese only, Sohei Makino, Comp.). The Guidelines on Diagnosis and Treatment of Asthma. Life Science Medica, Tokyo, 1993, 1-60.
7. Satoh, K., Imaizumi, T.-A., Kawamura, Y., Yoshida, H., Takamatsu, S., Takamatsu, M. Increased activity of the platelet-activating factor acetylhydrolase in plasma low density lipoprotein from patients with essential hypertension. Prostaglandins 1989, 37: 673-82.
8. 125I] RIA kit: Instruction manual for the measurement of platelet activating factor in biological fluids, E.I. Du Pont de Nemours & Co.
9. Staffonni, D.M., Prescott, S.M., McIntyre, T.M. Human plasma platelet-activating factor acetylhydrolase: Purification and properties. J Biol Chem 1987, 262: 4223-30.
10. Matsuzaki, M., Ishiguro, Y., Tetsumoto, T, Tsukada, Y., Kayahara, H., Tadasa, K. PAF acetylhydrolase activities in human systemic lupus erythematosus and lupus-prone mice. Clinica Chimica Acta 1992, 210: 139-44.
11. Gleich, G.J, Loegering, D A. Immunobiology of eosmophils. Ann Rev Immunol 1984, 2: 429-59.
12. Wardlaw, A.J., Moqbel, R., Cromwell, O., Kay, A.B. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest 1986, 78: 1701-6.
13. Pirotzky, E., Bidault, J., Burtin, C, Gubler, M.C, Benveniste, J. Release of platelet-activating factor, slow-reacting substance, and vasoactive species from isolated rat kidneys. Kidney Int 1984, 25: 404-10.
14. Blank, M.L., Lee, T.-C., Fitzgerald, V., Snyder, F A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid). J Biol Chem 1981, 256: 175-8.
15. Alam, I., Smith, J.B., Silver, M.J. Metabolism of platelet-activating factor by blood platelets and plasma. Lipids 1983, 18: 534-8.
16. Malone, B., Lee, T.-C., Snyder, F. Inactivation of platelet activating factor by rabbit platelets. J Biol Chem 1985, 260: 1531-4.
17. Lee, T -C., Malone, B, Wasserman, S.I., Fitzgerald, V., Snyder, F. Activities of enzymes that metabolize platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in neutrophils and eosinophils from humans and the effect of a calcium ionophore. Biochem Biophys Res Commun 1982, 105: 1303-8
18. Blank, M.L., Spector, A.A., Kaduce, T.L., Lee, T-C., Snyder, F. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells. Biochim Biophys Acta 1986, 876: 373-8.
19. Farr, R.S., Wardlow, M L., Cox, C.P., Meng, K.E., Greene, D.E. Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factor Fed Proc 1983, 42: 3120-2.
20. Grande, K.E., Wardlow, M.L., Farr, R.S. Platelet-activating factor in sputum of patients with asthma and COPD. J Allergy Clin Immunol 1985, 75: 184.
21. Stenton, S.C., Court, E.N., Kingston, W.P., Goadby, P., Kelly, C.A., Duddridge, M., Ward, C., Hendric, D.J., Walters, E.H. Platelet-activating factor in bronchoalveolar lavage fluid from asthmatic subjects. Eur Respir J 1990, 3: 408-13.
22. Honi, T, Okazaki, H, Kino, M., Kobayashi, Y., Satouchi, K., Saito, K. Platelet-activating factor detected in bronchoalveolar lavage fluids from an asthmatic patient. Lipids 1991, 26: 1292-6.
23. Hsieh, K.-H., Ng, C.-K. Increased plasma platelet-activating factor in children with acute asthmatic attacks and decreased in vivo and in vitro production of platelet-activating factor after immunotherapy. J Allergy Clin Immunol 1993, 91: 650-7.
24. Yamamoto, H., Nagata, M., Tabe, K., Kimura, I., Kiuchi, H., Sakamoto, Y, Yamamoto, K., Dohi, Y. The evidence of platelet activation in bronchial asthma J Allergy Clin Immunol 1993, 91: 79-87.
25. Lynch, J.M., Henson, P.M. The intracellular retention on newly synthesized platelet-activating factor. J Immunol 1986, 137 2653-61.
26. Henson, P.M. Extracellular and intracellular activities of platelet-activating factor. In: Winslow, C M., Lee, M.L. (Eds.). New Horizons in Platelet Activating Factor Research. John Wiley & Sons Ltd., New York 1987, 3-12.
27. Tufano, M.A., Tetta, C., Biancone, L., Iono, E.L., Baroni, A., Giovane, A., Camussi, G. Salmonella typhimurium porins stimulate platelet-activating factor synthesis by human polymorphonuclear neutrophils J Immunology 1992, 149: 1023-30.
28. Tufano, M.A., Biancone, L, Rossano, F., Capasso, C., Baroni, A., Martino, A.D., Iono, E.L., Silvestro, L., Camussi, G. Outer-membrane porins from Gram-negative bacteria stimulate platelet-activating-factor biosynthesis by cultured human endothelial cells. Eur J Biochem 1993, 214: 685-93.
29. Saton, K, Imaizumi, Y., Yoshida, H, Hiramoto, M, Takamatsu, S. Increased levels of blood platelet-activating factor (PAF) and PAF-like lipids in patients with ischemic stroke. Acta Neurol Scand 1992, 85: 122-7.
30. Satoh, K., Imaizumi, T., Kawamura, Y., Yoshida, H., Takamatsu, S., Mizono, S Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease. Prostaglandins 1988, 35: 685-98.
31. Chan-Yeung, M., Lam, S., Chan, H., Tse, K S, Salan, H. The release of platelet-activating factor into plasma during allergen-induced bronchoconstriction. J Allergy Clin Immunol 1991, 87: 667-73.
32. Miwa, M., Miyake, T., Yamanaka, T., Sugatani, J., Suzuki, Y., Sakata, S., Araki, Y., Matsumoto, M Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children J Clin Invest 1988, 82: 1983-91.